Header Logo

Connection

John Basgen to Glycation End Products, Advanced

This is a "connection" page, showing publications John Basgen has written about Glycation End Products, Advanced.
Connection Strength

0.089
  1. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature. 1996 Jul 18; 382(6588):275-8.
    View in: PubMed
    Score: 0.031
  2. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):3902-7.
    View in: PubMed
    Score: 0.031
  3. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol. 2006; 26(5):430-6.
    View in: PubMed
    Score: 0.016
  4. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 2002 Mar; 61(3):939-50.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.